Joel Pomerantz[Author - Full] - Search Results

Year	Number of Results
2002	3
2005	1
2008	1
2009	1
2010	3
2011	1
2012	2
2013	1
2014	1
2015	2
2016	5
2017	1
2018	2
2019	1
2020	3
2021	5
2022	2

1

Calcineurin inhibitors target Lck activation in graft-versus-host disease.

Carter NM, Pomerantz JL. Carter NM, et al. Among authors: pomerantz jl. J Clin Invest. 2021 Jun 1;131(11):e149934. doi: 10.1172/JCI149934. J Clin Invest. 2021. PMID: 34060488 Free article.

2

Efficient Immune Cell Genome Engineering with Enhanced CRISPR Editing Tools.

Chan W, Gottschalk RA, Yao Y, Pomerantz JL, Germain RN. Chan W, et al. Among authors: pomerantz jl. Immunohorizons. 2021 Feb 23;5(2):117-132. doi: 10.4049/immunohorizons.2000082. Immunohorizons. 2021. PMID: 33622708

3

HOIP for targeting diffuse large B-cell lymphoma.

Pomerantz JL. Pomerantz JL. Blood. 2020 Aug 6;136(6):646-647. doi: 10.1182/blood.2020006242. Blood. 2020. PMID: 32761216 Free article. No abstract available.

4

Reconsidering phosphorylation in the control of inducible CARD11 scaffold activity during antigen receptor signaling.

Pomerantz JL. Pomerantz JL. Adv Biol Regul. 2021 Jan;79:100775. doi: 10.1016/j.jbior.2020.100775. Epub 2020 Dec 18. Adv Biol Regul. 2021. PMID: 33358178 Free PMC article. Review.

5

Mechanisms of Regulated and Dysregulated CARD11 Signaling in Adaptive Immunity and Disease.

Bedsaul JR, Carter NM, Deibel KE, Hutcherson SM, Jones TA, Wang Z, Yang C, Yang YK, Pomerantz JL. Bedsaul JR, et al. Among authors: pomerantz jl. Front Immunol. 2018 Sep 19;9:2105. doi: 10.3389/fimmu.2018.02105. eCollection 2018. Front Immunol. 2018. PMID: 30283447 Free PMC article. Review.

6

Transcriptional target-based expression cloning of immunoregulatory molecules.

Lamason RL, Lew SM, Pomerantz JL. Lamason RL, et al. Among authors: pomerantz jl. Immunol Res. 2010 Jul;47(1-3):172-8. doi: 10.1007/s12026-009-8148-z. Immunol Res. 2010. PMID: 20069388 Free PMC article. Review.

7

Oxidized CaMKII and O-GlcNAcylation cause increased atrial fibrillation in diabetic mice by distinct mechanisms.

Mesubi OO, Rokita AG, Abrol N, Wu Y, Chen B, Wang Q, Granger JM, Tucker-Bartley A, Luczak ED, Murphy KR, Umapathi P, Banerjee PS, Boronina TN, Cole RN, Maier LS, Wehrens XH, Pomerantz JL, Song LS, Ahima RS, Hart GW, Zachara NE, Anderson ME. Mesubi OO, et al. Among authors: pomerantz jl. J Clin Invest. 2021 Jan 19;131(2):e95747. doi: 10.1172/JCI95747. J Clin Invest. 2021. PMID: 33151911 Free PMC article.

8

Pathway-Specific Defects in T, B, and NK Cells and Age-Dependent Development of High IgE in Mice Heterozygous for a CADINS-Associated Dominant Negative CARD11 Allele.

Hutcherson SM, Bedsaul JR, Pomerantz JL. Hutcherson SM, et al. Among authors: pomerantz jl. J Immunol. 2021 Aug 15;207(4):1150-1164. doi: 10.4049/jimmunol.2001233. Epub 2021 Aug 2. J Immunol. 2021. PMID: 34341167

9

Mechanistic impact of oligomer poisoning by dominant-negative CARD11 variants.

Bedsaul JR, Shah N, Hutcherson SM, Pomerantz JL. Bedsaul JR, et al. Among authors: pomerantz jl. iScience. 2022 Jan 22;25(2):103810. doi: 10.1016/j.isci.2022.103810. eCollection 2022 Feb 18. iScience. 2022. PMID: 35198875 Free PMC article.

10

CARD11 signaling in regulatory T cell development and function.

Carter NM, Pomerantz JL. Carter NM, et al. Among authors: pomerantz jl. Adv Biol Regul. 2022 Feb 26;84:100890. doi: 10.1016/j.jbior.2022.100890. Online ahead of print. Adv Biol Regul. 2022. PMID: 35255409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results